Colin O'Brady is a professional endurance athlete who has achieved four world records. He grew up exploring the mountains of the Pacific Northwest and cultivated a passion for adventure in the outdoors. His success swimming in Oregon led him to Yale University. After years as a professional triathlete, he returned to his first love - the mountains. In 2016 Colin conquered the speed records for the Explorers Grand Slam and Seven Summits, a global mountaineering challenge to climb the tallest mountain on every continent including Mt. Everest and ski to the North and South Poles. In 2018 Colin shattered the speed record for the 50 High Points Challenge when he summited the highest point in each of the 50 states in just 21 days. On December 26, 2018 he became the first person to cross the landmass of Antarctica solo, unaided by kites or resupplies. He accomplished the feat in 54 days, covering more than 930 miles along the way, including more than 77 miles in the final 32-hour window where he went without sleep. Throughout the nearly two-month journey, O’Brady never took a full day off.

Dan Buettner is an explorer, educator, author, and co-producer of an Emmy Award-winning documentary. He is also the founder of Blue Zones and holds three world records for endurance bicycling.

JOSHUA HARE is Chief Sciences Officer, Senior Associate Dean for Experimental and Cellular Therapeutics, Director of the Interdisciplinary Stem Cell Institute (ISCI), and Louis Lemberg Professor of Medicine at the University of Miami Miller School of Medicine. Dr. Hare is a practicing cardiologist with board certifications in cardiology and advanced heart failure and cardiac transplantation. During his research career, he has pioneered the use of allogenic adult cell therapy for multiple disease areas. Under his leadership, and in partnership with many faculty across the University of Miami campus, ISCI developed cell-based therapy programs in cancer biology, cardiology, aging, neonatology, skin diseases, bone diseases, neurologic diseases, ophthalmology, and a program devoted to the ethics of stem cell therapy.